News

Study finds spironolactone doesn’t boost breast cancer recurrence
Little is known about its use in treating alopecia in breast cancer survivors on endocrine therapies.
Little is known about its use in treating alopecia in breast cancer survivors on endocrine therapies.
He describes his experiences treating patients during this unsettling time.
According to the AAN, the easing of restrictions on telehealth should be extended beyond Medicare fee-for-service to both Medicare Advantage and...
Updated statement highlights injuries most common to abusive head trauma in children and infants.
Dr. Annie Luetkemeyer, professor of infectious diseases at UCSF, spoke with Dr. Robert Wachter, chair of the UCSF Department of Medcine, about the...
A 34-year-old man presented for evaluation of a slowly growing group of firm white bumps on the penis. The lesions were nontender and asymptomatic...
“We are providing maximum regulatory flexibility to facilitate an increase in ventilator inventory.”
Five percent of patients with rheumatoid arthritis given the live attenuated zoster vaccine before starting tofacitinib still developed shingles...